Cancer center tests new drug cocktail for Tough-to-Treat head and neck tumors
Disease control
Terminated
This study tested whether adding an experimental drug called magrolimab to standard cancer drugs could help control advanced head and neck cancer. It aimed to see if this combination could shrink tumors and was safe for patients. The trial was for adults whose cancer had returned…
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 06, 2026 14:17 UTC